Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.32%
#3 Velvet Velvet +36.95%
#4 Black Phoenix Black Phoenix +34.87%
#5 Akedo Akedo +23.18%
#6 Fake World Assets Fake World Assets +21.86%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.21%
#8 DoubleZero DoubleZero +16.03%
#9 HOME HOME +11.90%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.90%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Rang in aandelen #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Aandeelprijs
$0.00366968
Laatst gesynchroniseerd: 2024-07-12
Marktkapitalisatie
$299.46K
Verandering (1 dag)
-66.77%
Verandering (1 jaar)
0.00%
Land
CA
Handel Biocure Technology Inc. (CURE)

Categorie

Healthcare
P/S-ratio voor Biocure Technology Inc. (CURE)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Biocure Technology Inc. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Biocure Technology Inc. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE